| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.3 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |